阳普医疗
(300030)
| 流通市值：21.31亿 | | | 总市值：25.35亿 |
| 流通股本：2.60亿 | | | 总股本：3.09亿 |
| 报告期 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 一、营业总收入 | 115,535,431.63 | 581,328,009.09 | 421,468,424.66 | 293,161,345.69 |
| 营业收入 | 115,535,431.63 | 581,328,009.09 | 421,468,424.66 | 293,161,345.69 |
| 二、营业总成本 | 113,052,570.94 | 570,559,674.48 | 413,928,591.21 | 287,443,099.82 |
| 营业成本 | 69,102,507.91 | 340,698,710.81 | 252,701,132.63 | 175,775,125.32 |
| 税金及附加 | 1,705,587.25 | 8,643,965.27 | 6,466,081.16 | 4,838,625.31 |
| 销售费用 | 16,180,384.62 | 93,881,936.52 | 57,981,219.67 | 41,155,927.38 |
| 管理费用 | 19,201,718.48 | 86,876,673.17 | 65,667,453.05 | 46,306,139.37 |
| 研发费用 | 6,107,098.1 | 31,899,035.5 | 23,376,301.59 | 14,112,890.95 |
| 财务费用 | 755,274.58 | 8,559,353.21 | 7,736,403.11 | 5,254,391.49 |
| 其中:利息费用 | 1,734,247.37 | 11,089,765.57 | 9,290,301.4 | 6,919,098.94 |
| 其中:利息收入 | 671,485.13 | 1,817,943.86 | 1,432,358.02 | 974,971.15 |
| 加:公允价值变动收益 | - | -54,905,300 | -35,184,400 | 0 |
| 加:投资收益 | 4,353,325.29 | -8,652,614.47 | -12,979,218.06 | -12,301,561.61 |
| 资产处置收益 | 174,553.71 | 900,844.63 | 384,110.58 | 412,356.03 |
| 资产减值损失(新) | - | -47,201,039.26 | -166,748.49 | 6,008.07 |
| 信用减值损失(新) | - | -22,807,199.17 | -6,493,488.56 | -675,548.7 |
| 其他收益 | 1,520,363.72 | 4,968,066.27 | 6,022,099.69 | 4,027,521.13 |
| 营业利润平衡项目 | 0 | 0 | 0 | 0 |
| 四、营业利润 | 8,531,103.41 | -116,928,907.39 | -40,877,811.39 | -2,812,979.21 |
| 加:营业外收入 | 259,236.83 | 4,196,465.6 | 67,908.39 | 41,274.54 |
| 减:营业外支出 | 4,326.68 | 7,613,833.07 | 529,155.29 | 366,801.92 |
| 利润总额平衡项目 | 0 | 0 | 0 | 0 |
| 五、利润总额 | 8,786,013.56 | -120,346,274.86 | -41,339,058.29 | -3,138,506.59 |
| 减:所得税费用 | 931,065.73 | -447,112.98 | 3,293,277.28 | 1,367,951.21 |
| 六、净利润 | 7,854,947.83 | -119,899,161.88 | -44,632,335.57 | -4,506,457.8 |
| 持续经营净利润 | 7,854,947.83 | -119,899,161.88 | -44,632,335.57 | -4,506,457.8 |
| 归属于母公司股东的净利润 | 7,808,417.76 | -117,903,784.23 | -42,517,592.38 | -5,275,309.54 |
| 少数股东损益 | 46,530.07 | -1,995,377.65 | -2,114,743.19 | 768,851.74 |
| (一)基本每股收益 | 0.03 | -0.38 | -0.14 | -0.02 |
| (二)稀释每股收益 | 0.03 | -0.38 | -0.14 | -0.02 |
| 八、其他综合收益 | 558.24 | 1,553,766.86 | 17,683.97 | 11,419.19 |
| 归属于母公司股东的其他综合收益 | 558.24 | 1,553,766.86 | 17,683.97 | 11,419.19 |
| 九、综合收益总额 | 7,855,506.07 | -118,345,395.02 | -44,614,651.6 | -4,495,038.61 |
| 归属于母公司股东的综合收益总额 | 7,808,976 | -116,350,017.37 | -42,499,908.41 | -5,263,890.35 |
| 归属于少数股东的综合收益总额 | 46,530.07 | -1,995,377.65 | -2,114,743.19 | 768,851.74 |
| 公告日期 | 2025-04-25 | 2025-04-25 | 2024-10-26 | 2024-08-15 |
| 审计意见(境内) | | 标准无保留意见 | | |